| 000 | 01803 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516090757.0 | ||
| 264 | 0 | _c20121213 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-012-2050-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeidemann, Simone | |
| 245 | 0 | 0 |
_aDouble heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cAug 2012 |
||
| 300 |
_a1229-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aEthnicity _xgenetics |
| 650 | 0 | 4 | _aFamily |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aGenes, BRCA2 |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aFischer, Christine | |
| 700 | 1 | _aEngel, Christoph | |
| 700 | 1 | _aFischer, Barbara | |
| 700 | 1 | _aHarder, Lana | |
| 700 | 1 | _aSchlegelberger, Brigitte | |
| 700 | 1 | _aNiederacher, Dieter | |
| 700 | 1 | _aGoecke, Timm O | |
| 700 | 1 | _aDoelken, Sandra C | |
| 700 | 1 | _aDikow, Nicola | |
| 700 | 1 | _aJonat, Walter | |
| 700 | 1 | _aMorlot, Susanne | |
| 700 | 1 | _aSchmutzler, Rita C | |
| 700 | 1 | _aArnold, Norbert K | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 134 _gno. 3 _gp. 1229-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-012-2050-4 _zAvailable from publisher's website |
| 999 |
_c21732961 _d21732961 |
||